chr21-32638903-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBS1BS2
The NM_203446.3(SYNJ1):c.3915+5G>T variant causes a splice region, intron change. The variant allele was found at a frequency of 0.00232 in 1,588,414 control chromosomes in the GnomAD database, including 88 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 47 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 41 hom. )
Consequence
SYNJ1
NM_203446.3 splice_region, intron
NM_203446.3 splice_region, intron
Scores
2
Splicing: ADA: 0.9991
2
Clinical Significance
Conservation
PhyloP100: 5.34
Publications
2 publications found
Genes affected
SYNJ1 (HGNC:11503): (synaptojanin 1) This gene encodes a phosphoinositide phosphatase that regulates levels of membrane phosphatidylinositol-4,5-bisphosphate. As such, expression of this enzyme may affect synaptic transmission and membrane trafficking. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
SYNJ1 Gene-Disease associations (from GenCC):
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 53Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- early-onset Parkinson disease 20Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- atypical juvenile parkinsonismInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- young-onset Parkinson diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. Scorers claiming Uncertain: max_spliceai. No scorers claiming Benign.
BP6
Variant 21-32638903-C-A is Benign according to our data. Variant chr21-32638903-C-A is described in ClinVar as Benign. ClinVar VariationId is 478342.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0126 (1913/152196) while in subpopulation AFR AF = 0.0435 (1803/41494). AF 95% confidence interval is 0.0418. There are 47 homozygotes in GnomAd4. There are 875 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 47 AR,AD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0126 AC: 1911AN: 152078Hom.: 47 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1911
AN:
152078
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00318 AC: 769AN: 241836 AF XY: 0.00223 show subpopulations
GnomAD2 exomes
AF:
AC:
769
AN:
241836
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00124 AC: 1780AN: 1436218Hom.: 41 Cov.: 30 AF XY: 0.00106 AC XY: 757AN XY: 711406 show subpopulations
GnomAD4 exome
AF:
AC:
1780
AN:
1436218
Hom.:
Cov.:
30
AF XY:
AC XY:
757
AN XY:
711406
show subpopulations
African (AFR)
AF:
AC:
1446
AN:
32506
American (AMR)
AF:
AC:
92
AN:
41312
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25028
East Asian (EAS)
AF:
AC:
0
AN:
39220
South Asian (SAS)
AF:
AC:
5
AN:
84120
European-Finnish (FIN)
AF:
AC:
0
AN:
53004
Middle Eastern (MID)
AF:
AC:
8
AN:
5622
European-Non Finnish (NFE)
AF:
AC:
73
AN:
1096230
Other (OTH)
AF:
AC:
156
AN:
59176
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
86
173
259
346
432
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0126 AC: 1913AN: 152196Hom.: 47 Cov.: 32 AF XY: 0.0118 AC XY: 875AN XY: 74414 show subpopulations
GnomAD4 genome
AF:
AC:
1913
AN:
152196
Hom.:
Cov.:
32
AF XY:
AC XY:
875
AN XY:
74414
show subpopulations
African (AFR)
AF:
AC:
1803
AN:
41494
American (AMR)
AF:
AC:
88
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5192
South Asian (SAS)
AF:
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
AC:
0
AN:
10572
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7
AN:
68020
Other (OTH)
AF:
AC:
15
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
99
198
298
397
496
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jun 14, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 10, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Early-onset Parkinson disease 20;C4479313:Developmental and epileptic encephalopathy, 53 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 5
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.